Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study

Dr Chaya Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA
The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study ( Dr Chaya Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )
17 Dec 2012

Breast cancer hypo-fractionated radiotherapy offers long-term tumour control

Prof John Yarnold – Institute of Cancer Research and Royal Marsden Hospital, UK
Breast cancer hypo-fractionated radiotherapy offers long-term tumour control ( Prof John Yarnold – Institute of Cancer Research and Royal Marsden Hospital, UK )
12 Dec 2012

Fewer, bigger doses of radiotherapy benefit cancer patients

Prof John Yarnold - Institute of Cancer Research and Royal Marsden Hospital, UK
Fewer, bigger doses of radiotherapy benefit cancer patients ( Prof John Yarnold - Institute of Cancer Research and Royal Marsden Hospital, UK )
6 Dec 2012

Late effects of treatment in gynaecological cancers

Dr Remi Nout – Leiden University Medical Center, Netherlands
Late effects of treatment in gynaecological cancers ( Dr Remi Nout – Leiden University Medical Center, Netherlands )
30 Oct 2012

Chemotherapy and radiotherapy in advanced local non-small cell lung cancer

Dr Dirk De Ruysscher – University of Leuven, Netherlands
Chemotherapy and radiotherapy in advanced local non-small cell lung cancer ( Dr Dirk De Ruysscher – University of Leuven, Netherlands )
12 Oct 2012

Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)

Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012

Clinical trials and drug developments in pancreatic cancer

Dr Roberto Labianca – Ospedali Riuniti Bergamo, Italy
Clinical trials and drug developments in pancreatic cancer ( Dr Roberto Labianca – Ospedali Riuniti Bergamo, Italy )
9 Oct 2012

Multidisciplinary benefits to radiotherapy

Prof Vincenzo Valentini – President of ESTRO
Multidisciplinary benefits to radiotherapy ( Prof Vincenzo Valentini – President of ESTRO )
9 Oct 2012

Advances in radiotherapy for rectal cancer

Dr Karin Haustermans – University Hospital Leuven, Belgium
Advances in radiotherapy for rectal cancer  ( Dr Karin Haustermans – University Hospital Leuven, Belgium )
16 Jul 2012

Reducing radiotherapy for Hodgkin's lymphoma while maintaining the highest cure rate

Prof Andreas Engert - University Hospital of Cologne, Germany
Reducing radiotherapy for Hodgkin's lymphoma while maintaining the highest cure rate ( Prof Andreas Engert - University Hospital of Cologne, Germany )
22 Jun 2012

BRCA carrier status as a prognostic factor for prostate cancer

Dr Elena Castro - The Institute of Cancer Research, Sutton, UK
BRCA carrier status as a prognostic factor for prostate cancer ( Dr Elena Castro - The Institute of Cancer Research, Sutton, UK )
20 Jun 2012

Combined chemo-radiation extends survival for anaplastic oligodendroglial tumours

Prof Martin van den Bent - Erasmus University Medical Center, Rotterdam, The Netherlands
Combined chemo-radiation extends survival for anaplastic oligodendroglial tumours ( Prof Martin van den Bent - Erasmus University Medical Center, Rotterdam, The Netherlands )
20 Jun 2012